Robert Greene, MD
Orthopaedic Surgery · Yakima, WANPI 1952350639
Payments from drug & device makers
Across 175 payments — averaging $61.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Encore Medical, LP$2K
- Pacira Pharmaceuticals Incorporated$2K
- Medacta USA, Inc.$133
- Heron Therapeutics, Inc.$40
- Boston Scientific$26
- plus $43 from 3 others
What the payments were for
- Consulting fees$2252%
- Speaking & faculty fees$2,50023%
- Travel & lodging$4634%
- Food & beverage$7,59970%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 152 | $6,992 |
| Encore Medical, LP | 9 | $1,856 |
| Pacira Pharmaceuticals Incorporated | 6 | $1,697 |
| Medacta USA, Inc. | 2 | $133 |
| Heron Therapeutics, Inc. | 2 | $40 |
| Boston Scientific | 1 | $26 |
| Amniox Medical, Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $12 |
| KCI USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$1,564
- MAKO$351
- NONE$130
- MOTO UNI$121
- DJO SURGICAL$117
How this compares
$10,787 in reported general payments places this provider in the 75th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $5,001 |
| Oxycodone Hcl | 185 | $910 |
| Omeprazole | 78 | $533 |
| Ondansetron OdtOndansetron | 31 | $303 |
| Methylprednisolone | 24 | $293 |
| Cephalexin | 119 | $277 |
| Amoxicillin | 82 | $128 |
| Meloxicam | 34 | $124 |
| Hydroxyzine Pamoate | 13 | $73 |
| Tramadol Hcl | 31 | $56 |
| Hydromorphone Hcl | 13 | $46 |
| Clindamycin Hcl | 15 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Yakima
- William BarrettRenton$8.2M
- James PritchettSeattle$6.4M
- Jeffrey RohSeattle$4.7M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Timothy AltonRenton$1.8M
- Burt YaszaySeattle$1.5M
- Sean ToomeySeattle$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.